We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.15 | -1.62% | 9.10 | 8.70 | 9.50 | 9.25 | 9.10 | 9.25 | 321,812 | 14:04:44 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.05 | 84.43M |
Date | Subject | Author | Discuss |
---|---|---|---|
31/7/2023 12:56 | Dom....the only nonsense is not having any method whatsoever....or any premise whatsoever....like you happy clappers. Let's be totally clear here....the technicals have been spot on. The fundamentalists have been TOTALLY WRONG ! | 2tyke | |
31/7/2023 12:36 | FFS tyke. Which Wave are we getting and which direction. Or, is it all really nonsense? | dominiccummings | |
31/7/2023 12:26 | Count....yes ..as outlined in here ...in advance. I prefer to call it the 'current bottom' though as the downtrend has not yet been broken. Chill time....I know...you only stare at your screen all day when the share price goes up ! Panama ...not much of relevance occurs to the happy-clappers ! | 2tyke | |
31/7/2023 10:29 | Don't suppose any 'clappers' are CONtemplating the chances of the 'flock' getting SPIKED ??? AGAIN | the real lozan | |
31/7/2023 10:00 | Can someone posting on LSE tell Jak to scan to the bottom for recruitment contacts. Contact: Robert Miller Jak002 RE: Modi-1 Expansion RNSToday 09:51 Hi folks, Would anyone here be able to point me towards the recruiting organisation for the expanded cohort? Thanks in advance...... | marcusl2 | |
31/7/2023 09:31 | Beware of false gods, Count ;-) | markingtime | |
31/7/2023 09:23 | 2tyke, We all have different investment strategies for different types of shares. I’m a longer term investor so I look at risk/reward rather than trading sentiment. I don’t get emotional about daily movements. I used to be a very active trader 15+ years ago but these days I prefer to spend my time on other things….not looking at a screen all day. | chillpill | |
31/7/2023 09:23 | 2Tyke, Of course you bought at the exact bottom, to the penny. You're so perfect. We all worship you! | countbruga | |
31/7/2023 09:20 | Lol...you've just gotta laugh at some of those clowns over at LSE ...'hope nobody was panicked into selling at 9p '! Lol After the clown has held from 29p ! | 2tyke | |
31/7/2023 09:19 | Cat tykes are spider-like, egg-shaped, blood-sucking creepy crawlies. They have six to eight legs (depending on their life stage) Gone Surfing wave is up | inanaco | |
31/7/2023 09:13 | The only thing that's new Markingtime is that you are back posting .....reacting to the share price moves in hindsight again. The technical people have already taken their positions close to the bottom....not held their positions from the top like you did....on greed. | 2tyke | |
31/7/2023 09:09 | Burble I will be really interested to see what the AGM data this year looks like. By then we should have nice lengths of time from the early cohorts, further data from the monotherapy cohorts and some nice data coming in from the CPI cohorts. In turn I hope to see some histology images of H&E stained slides from pre- and post-resected tumour. It hopefully will be very exciting! | marcusl2 | |
31/7/2023 09:05 | Its new.We have a FOMO rally starting..... | markingtime | |
31/7/2023 09:03 | In the announcement today about patient showing tumor regression is that something that was announced previously and we already know or is this new information? | octopus100 | |
31/7/2023 08:37 | It is worth remembering that few institutions have a position of any sort here. If, by the time of the AGM, Scancell have first results back from head and neck resections, many institutions will be suddenly wishing they'd acted now. | markingtime | |
31/7/2023 08:18 | Repeat again Modi1 works ....... we have killer CD4 t cells now we shape the environment to give them the best chance we are in control because we have the "working element" and for the first time in a few months a "direct look" inside the cancer to see exactly what is going on its a fantastic trial in that it covers all bases with the backdrop now, we know we have some synergy with SCIB1 .... and checkpoints with 73% of that trial recruited .... | inanaco | |
31/7/2023 08:14 | Good news this morning | pal44 | |
31/7/2023 08:12 | As expected and hoped that Modi-1 will work best at Cohort 4 (High Dose plus CPI) ; 1st patient on High Dose plus CPI...... Tumour Regression Excellent news. | marcusl2 | |
31/7/2023 08:02 | The Doomsters buy back begins .... | inanaco | |
31/7/2023 08:00 | Good news today. If more than just the first patient shows tumour shrinkage then it could fly.Something must be going right to get approval for a bigger-than-expected expansion (don't think the surgery candidates were expected just yet?). | markingtime | |
31/7/2023 07:22 | No negatives in there! Glad I topped up. All the major immunotherapy companies willbe watching very carefully. | chillpill | |
31/7/2023 07:14 | First (and so far the only) patient assessed in cohort 4 has shown tumour regression - sounds promising... | miavoce | |
31/7/2023 07:05 | NewsHTTps://www.voxm | pharmaboy3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions